BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11899265)

  • 1. Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules.
    Miskovsky P
    Curr Drug Targets; 2002 Feb; 3(1):55-84. PubMed ID: 11899265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
    Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
    PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy.
    Kiesslich T; Krammer B; Plaetzer K
    Curr Med Chem; 2006; 13(18):2189-204. PubMed ID: 16918348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds.
    Verebová V; Beneš J; Staničová J
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypericins as potential leads for new therapeutics.
    Karioti A; Bilia AR
    Int J Mol Sci; 2010 Feb; 11(2):562-94. PubMed ID: 20386655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro.
    Barras A; Boussekey L; Courtade E; Boukherroub R
    Nanoscale; 2013 Nov; 5(21):10562-72. PubMed ID: 24056802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).
    Peebles KA; Baker RK; Kurz EU; Schneider BJ; Kroll DJ
    Biochem Pharmacol; 2001 Oct; 62(8):1059-70. PubMed ID: 11597574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypericin--the facts about a controversial agent.
    Kubin A; Wierrani F; Burner U; Alth G; Grünberger W
    Curr Pharm Des; 2005; 11(2):233-53. PubMed ID: 15638760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypericin in cancer treatment: more light on the way.
    Agostinis P; Vantieghem A; Merlevede W; de Witte PA
    Int J Biochem Cell Biol; 2002 Mar; 34(3):221-41. PubMed ID: 11849990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell toxicity of hypericin and related analogs.
    Wills NJ; Park J; Wen J; Kesavan S; Kraus GA; Petrich JW; Carpenter S
    Photochem Photobiol; 2001 Aug; 74(2):216-20. PubMed ID: 11547558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromohypericins are potent photoactive antiviral agents.
    Hudson JB; Delaey E; de Witte PA
    Photochem Photobiol; 1999 Nov; 70(5):820-2. PubMed ID: 10568175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro study of photodynamic activity of hypericin and hypericinates in MCF-7 cells.
    de Andrade GP; Manieri TM; Nunes EA; Viana GM; Cerchiaro G; Ribeiro AO
    J Photochem Photobiol B; 2017 Oct; 175():89-98. PubMed ID: 28865319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of hypericin and hypocrellin-induced phototoxicity by omeprazole.
    Mirossay A; Mirossay L; Tóthová J; Miskovský P; Onderková H; Mojzis J
    Phytomedicine; 1999 Nov; 6(5):311-7. PubMed ID: 11962536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
    Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
    Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multifaceted photocytotoxic profile of hypericin.
    Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
    Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of oxygen and photoinduced acidification in the light-dependent antiviral activity of hypocrellin A.
    Fehr MJ; Carpenter SL; Wannemuehler Y; Petrich JW
    Biochemistry; 1995 Dec; 34(48):15845-8. PubMed ID: 7495816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells.
    Jendželovská Z; Jendželovský R; Hiľovská L; Kovaľ J; Mikeš J; Fedoročko P
    Toxicol In Vitro; 2014 Oct; 28(7):1259-73. PubMed ID: 24994473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericin as an inactivator of infectious viruses in blood components.
    Lavie G; Mazur Y; Lavie D; Prince AM; Pascual D; Liebes L; Levin B; Meruelo D
    Transfusion; 1995 May; 35(5):392-400. PubMed ID: 7740610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of antiviral and antitumor photoactive drug hypocrellin A with human serum albumin.
    Kocisová E; Jancura D; Sánchez-Cortés S; Miskovský P; Chinsky L; García-Ramos JV
    J Biomol Struct Dyn; 1999 Aug; 17(1):111-20. PubMed ID: 10496426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericin as a promising natural bioactive naphthodianthrone: A review of its pharmacology, pharmacokinetics, toxicity, and safety.
    Peng Z; Lu J; Liu K; Xie L; Wang Y; Cai C; Yang D; Xi J; Yan C; Li X; Shi M
    Phytother Res; 2023 Dec; 37(12):5639-5656. PubMed ID: 37690821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.